- Home
- IMTX vs PAXS Comparison
IMTX vs PAXS Comparison
Compare IMTX & PAXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- PAXS
- Stock Information
- Founded
- IMTX N/A
- PAXS 2021
- Country
- IMTX Germany
- PAXS United States
- Employees
- IMTX N/A
- PAXS N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- PAXS Investment Managers
- Sector
- IMTX Health Care
- PAXS Finance
- Exchange
- IMTX Nasdaq
- PAXS Nasdaq
- Market Cap
- IMTX 653.9M
- PAXS 723.1M
- IPO Year
- IMTX N/A
- PAXS N/A
- Fundamental
- Price
- IMTX $6.26
- PAXS $16.18
- Analyst Decision
- IMTX Strong Buy
- PAXS
- Analyst Count
- IMTX 4
- PAXS 0
- Target Price
- IMTX $14.67
- PAXS N/A
- AVG Volume (30 Days)
- IMTX 984.5K
- PAXS 195.0K
- Earning Date
- IMTX 08-13-2025
- PAXS 01-01-0001
- Dividend Yield
- IMTX N/A
- PAXS 11.72%
- EPS Growth
- IMTX N/A
- PAXS N/A
- EPS
- IMTX N/A
- PAXS N/A
- Revenue
- IMTX $152,823,253.00
- PAXS N/A
- Revenue This Year
- IMTX N/A
- PAXS N/A
- Revenue Next Year
- IMTX N/A
- PAXS N/A
- P/E Ratio
- IMTX N/A
- PAXS N/A
- Revenue Growth
- IMTX 83.61
- PAXS N/A
- 52 Week Low
- IMTX $3.30
- PAXS $12.57
- 52 Week High
- IMTX $13.09
- PAXS $15.93
- Technical
- Relative Strength Index (RSI)
- IMTX 58.89
- PAXS 81.57
- Support Level
- IMTX $5.29
- PAXS $15.46
- Resistance Level
- IMTX $5.56
- PAXS $16.06
- Average True Range (ATR)
- IMTX 0.35
- PAXS 0.12
- MACD
- IMTX 0.04
- PAXS 0.03
- Stochastic Oscillator
- IMTX 85.03
- PAXS 91.68
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.